Patents Assigned to Validus Genetics
  • Publication number: 20130079316
    Abstract: The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as inhibitors of NF-?B for the treatment or prevention of muscular wasting disease, including muscular dystrophy.
    Type: Application
    Filed: November 15, 2012
    Publication date: March 28, 2013
    Applicant: Validus Genetics
    Inventor: Validus Genetics
  • Patent number: 8334279
    Abstract: The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as inhibitors of NF-?B for the treatment or prevention of muscular wasting disease, including muscular dystrophy.
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: December 18, 2012
    Assignee: Validus Genetics
    Inventors: John M. McCall, Eric Hoffman, Kanneboyina Nagaraju
  • Publication number: 20120094970
    Abstract: The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as inhibitors of NF-?B for the treatment or prevention of muscular wasting disease, including muscular dystrophy.
    Type: Application
    Filed: December 15, 2011
    Publication date: April 19, 2012
    Applicant: VALIDUS GENETICS
    Inventors: John M. McCall, Eric Hoffman, Kanneboyina Nagaraju
  • Publication number: 20100087408
    Abstract: The present invention relates to compounds and methods which may be useful as treatments of neuromuscular diseases such as muscular dystrophy, and as inhibitors of NF-?B for the treatment or prevention of muscular wasting disease, including muscular dystrophy.
    Type: Application
    Filed: May 28, 2009
    Publication date: April 8, 2010
    Applicant: VALIDUS GENETICS
    Inventors: John M. McCall, Eric Hoffman, Kanneboyina Nagaraju